Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2022-05-25

FDA Approved: ZONISAMIDE — Supplemental Application (Viona Pharmaceuticals Inc)

View source ↗

Summary

The FDA approved a supplemental application for Zonisamide from Viona Pharmaceuticals Inc, resulting in changes to the product label.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonisamide (zonisamide)

Snippet

SUPPL AP for ZONISAMIDE (ZONISAMIDE)